The first enzyme platform purpose-built for diverse, scalable ncAA synthesis. A process that is elegant, green, and unlocks chemical diversity.

01Science

Discover the innovative science behind our game-changing ncAAs.

01Enzyme Engineering

Through directed evolution, we create specific enzymes for noncanonical amino acid synthesis. Our focus is on both breadth and practicality: enzymes that open access to wide chemical diversity while remaining highly active. This platform makes ncAAs not just possible to imagine, but also practical to produce.

02Biocatalysis

Our engineered enzymes perform biocatalysis at high concentrations in water, minimizing use of solvents and hazardous materials, and optimizing process mass intensity. These reactions routinely reach >90% yields within hours, providing an efficient, sustainable route to noncanonical amino acids at manufacturing scale.

03 Downstream Processing

After biocatalysis, ncAAs are isolated by filtration or recrystallization—no chromatography required. Subsequent derivatization yields protected variants, including Fmoc and Boc.

01Enzyme Engineering

Through directed evolution, we create specific enzymes for noncanonical amino acid synthesis. Our focus is on both breadth and practicality: enzymes that open access to wide chemical diversity while remaining highly active. This platform makes ncAAs not just possible to imagine, but also practical to produce.

02Biocatalysis

Our engineered enzymes perform biocatalysis at high concentrations in water, minimizing use of solvents and hazardous materials, and optimizing process mass intensity. These reactions routinely reach >90% yields within hours, providing an efficient, sustainable route to noncanonical amino acids at manufacturing scale

03 Downstream Processing

After biocatalysis, ncAAs are isolated by filtration or recrystallization—no chromatography required. Subsequent derivatization yields protected variants, including Fmoc and Boc.

Enzyme Engineering1

Through directed evolution, we create specific enzymes for noncanonical amino acid synthesis. Our focus is on both breadth and practicality: enzymes that open access to wide chemical diversity while remaining highly active. This platform makes ncAAs not just possible to imagine, but also practical to produce.

Biocatalysis2

Our engineered enzymes perform biocatalysis at high concentrations in water, minimizing use of solvents and hazardous materials, and optimizing process mass intensity. These reactions routinely reach >90% yields within hours, providing an efficient, sustainable route to noncanonical amino acids at manufacturing scale.

Downstream Processing3

After biocatalysis, ncAAs are isolated by filtration or recrystallization—no chromatography required. Subsequent derivatization yields protected variants, including Fmoc and Boc.

02Quality

High-purity building blocks, traceable supply chain, and experienced QA/QC support that’s designed to meet the demands of pharmaceutical manufacturing.

A Qualified Supply Partner

Certified, documented, and trusted by leading API manufacturers to deliver consistency at scale.

ISO 9001:2015 certified since 2022 by DEKRA

Product documentation and traceability, including certificate of analysis and analytics

U.S.-based, sustainable manufacturing for reliable delivery
at scale

Qualified supplier with major API manufacturers

Manufacturing at all Scales

We deliver the quality you need, from early discovery through commercial development.

USP <1504> compliant starting materials for therapeutics

>95% purity for drug discovery and 
pre-clinical applications

>99% purity with <0.1% of any single impurity, >99% ee, TSE/BSE free for clinical and commercial batches

Batch sizes up to 100 kilograms, supporting scale up and process validation

Experienced Quality Team

Decades of pharmaceutical QA/QC and analytical chemistry expertise to safeguard every batch.

ISO 9001, quality assurance, and quality control for pharmaceutical products.

Analytical chemistry experience in method development and release testing

Enzyme Engineering1

Through directed evolution, we create specific enzymes for noncanonical amino acid synthesis. Our focus is on both breadth and practicality: enzymes that open access to wide chemical diversity while remaining highly active. This platform makes ncAAs not just possible to imagine, but also practical to produce.

Biocatalysis2

Through directed evolution, we create specific enzymes for noncanonical amino acid synthesis. Our focus is on both breadth and practicality: enzymes that open access to wide chemical diversity while remaining highly active. This platform makes ncAAs not just possible to imagine, but also practical to produce.

Downstream Processing3

After biocatalysis, ncAAs are isolated by filtration or recrystallization—no chromatography required. Subsequent derivatization yields protected variants, including Fmoc and Boc.

Enzyme Engineering1

Through directed evolution, we create specific enzymes for noncanonical amino acid synthesis. Our focus is on both breadth and practicality: enzymes that open access to wide chemical diversity while remaining highly active. This platform makes ncAAs not just possible to imagine, but also practical to produce.

Biocatalysis2

Through directed evolution, we create specific enzymes for noncanonical amino acid synthesis. Our focus is on both breadth and practicality: enzymes that open access to wide chemical diversity while remaining highly active. This platform makes ncAAs not just possible to imagine, but also practical to produce.

Downstream Processing3

After biocatalysis, ncAAs are isolated by filtration or recrystallization—no chromatography required. Subsequent derivatization yields protected variants, including Fmoc and Boc.

A Qualified Supply Partner

Certified, documented, and trusted by leading API manufacturers to deliver consistency at scale.

ISO 9001:2015 certified since 2022 by DEKRA
Product documentation and traceability, including certificate of analysis and analytics
U.S.-based, sustainable manufacturing for reliable delivery 
at scale
Qualified supplier with major API manufacturers
Manufacturing at all Scales

We deliver the quality you need, from early discovery through commercial development.

USP <1504> compliant starting materials for therapeutics
>95% purity for drug discovery and 
pre-clinical applications
>99% purity with <0.1% of any single impurity, >99% ee, TSE/BSE free for clinical and commercial batches
Batch sizes up to 100 kilograms, supporting scale up and process validation
Experienced Quality Team

Decades of pharmaceutical QA/QC and analytical chemistry expertise to safeguard every batch.

ISO 9001, quality assurance, and quality control for pharmaceutical products and medical devices
Analytical chemistry experience in method development and release testing

03Sustainability

Our enzyme platform is best-in-class, outperforming traditional manufacturing approaches by 10–100x across energy, waste, and carbon emissions.

Sustainable Process

Parameters for each method to make 100 kilograms of ncAA.

Parameters for each method to make 100
kilograms of ncAA.
Number of Steps
1
7
Synthesis Time
12 hours
135 hours
Yield
>90%
18%
Reactor Volume
250 gallons
8000 gallons
Hazardous Materials
None
31 tons
ncAA Diversity
Approaching 100%
<10%

Sustainable Byproducts

Biocatalysis significantly reduces waste, energy, and emissions when compared to traditional ncAA manufacturing approaches.

Mass Index
98%
less waste
Lifecycle Energy
99%
less waste
CO2
98%
less waste
Biocatalysis significantly reduces waste, energy, and
emissions when compared to traditional ncAA
manufacturing approaches.
Mass Index
98%
less waste
Lifecycle Energy
98%
less waste
CO2
96%
less CO2
98%less waste
99%less energy
96%less CO2

Sustainable Promise

Select Quantity
Product Name
Product ID
11785
CAS
321455-12-9
Purity
<97%
Product details  ↗
Quantity
Availability
Price
Product Variants
Request Bulk Quote ↗